Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients

Altar CA, Wasley AM, Neale RF, Stone GA (1986) Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain. Brain Res Bull 16: 517–525

Andorn AC, Huang EH, Warren AE (1984) Specific [3H]-spiroperidol binding sites in human prefrontal cortex: potential site multiplicity and overall serotonin-like selectively. Life Sci 34: 2461–2466

Andreé TH, Mikuni M, Tong CY, Koenig JI, Meltzer HY (1986) Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex. J Neurochem 46: 191–197

Arora RC, Meltzer HY (1989) Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry 146: 730–736

Bennett JP, Enna SJ, Bylund DB, Gillin JC, Wyatt RJ, Snyder SH (1979) Neurotransmitter receptors in frontal cortex of schizophrenics. Arch Gen Psychiatry 36: 927–934

Biegon A, Kargman S, Snyder L, McEwen BS (1986) Characterisation and localisation of serotonin receptors in human brain postmortem. Brain Res 353: 91–98

Bleich A, Brown S, Kahn R, van Praag H (1988) The role of serotonin in schizophrenia. Schizophr Bull 14: 297–315

Camus A, Javoy-Agid F, Dubois A, Scatton B (1986) Autoradiographic localization and quantification of dopamine D2 receptors in normal human brain with [3H]N-n-propylnorapomorphine. Brain Res 375: 135–149

Camps M, Cortes R, Gueye B, Probst A, Palacios JM (1989) Dopamine receptors in human brain: autoradiographic distribution of D2 sites. Neuroscience 28: 275–290

Cheetham SC, Crompton MR, Katona CLE, Horton RW (1988) Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Res 443: 272–280

Chivers J, Jenner P, Marsden CD (1987) Pharmacological chracterization of binding sites identified in rat brain following in vivo administration of [3H]-spiperone. Br J Pharmacol 90: 467–478

De Keyser J, De Backer J-P, Ebinger G, Vauqueline G (1985) Regional distribution of the dopamine D2 receptors in the mesotelencephalic dopamine neurons systems of human brain. J Neurol Sci 71: 119–127

De Keyser J, Claeys A, De-Backer J-P, Ebinger G, Roels F, Vanquelin G (1988) Autoradiographic localization of D1 and D2 dopamine receptors in the human brain. Neurosci Lett 91: 142–147

Engel G, Muller-Schweinitzer E, Palacios JM (1984) 2-[125Iodo]LSD, a new ligand for the characterization and localization of 5-HT2 receptors. Naunyn-Schiedebergs Arch Pharmacol 325: 328–336

Gross-Isseroff R, Salama D, Israeli M, Biegon A (1990) Autoradiographic analysis of agedependent changes in serotonin 5-HT2 receptors of the human brain postmortem. Brain Res 519: 223–227

Lee T, Tang SW (1984) Loxapine and clozpaine decrease serotonin (S2) but do not elevate dopamine (D2) receptor numbers in the rat brain. Psychiatry Res 12: 277–285

Levin S (1984) Frontal lobe dysfunctions in schizophrenia. II. Impairments of psychological and brain functions. J Psychiatry Res 18: 57–72

Leysen JE, Niemegeers CJE, Tollenaere JP, Laduron PM (1978) Serotonergic component of neuroleptic receptors. Nature 272: 168–171

Liskowsky DR, Potter LT (1985) D-2 dopamine receptors in the frontal cortex of rat and human. Life Sci 36: 1551–1559

Mackay AVP, Doble A, Bird ED, Spokes EG, Ouik M, Iversen LL (1978)3H-Spiperone binding in normal and schizophrenic post-mortem human brain. Life Sci 23: 527–532

Mann JJ, Stanley M, McBride PA, McEwen BS (1986) Increased serotonin2 and β-adrenergic receptor binding in frontal cortex of suicide victims. Arch J Psychiatry 43: 954–959

Matsubara S, Meltzer HY (1989) Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex. Life Sci 45: 1397–1406

Meltzer HY (1989) Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology 99: S 18-S 27

Meltzer HY, Matsubara S, Lee J-C (1989) Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exp Ther 251: 238–246

Meltzer HY (1987) Biological studies in schizophrenia. Schizophr Bull 13: 77–111

Mita T, Kuno T, Nakai H, Tanaka C (1982) Evidence for the presence of D2 and 5-HT2 receptors in the human prefrontal cortex. Jap J Pharmacol 32: 1027–1032

Mita T, Hanada S, Nishimo N, Kuno T, Nakai H, Yamadori R, Mizoi Y, Tanaka C (1986) Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics. Biol Psychiatry 21: 1407–1414

O'Dell SJ, La Hoste GJ, Widmark CB, Shapiro RM, Potkin SG, Marshall JF (1990) Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptor in rat brain. Synapse 6: 146–153

Owen F, Cross AJ, Crow TJ, Lofthouse R, Poulter M (1981) Neurotransmitter receptors in brain in schizophrenia. Acta Psychiatr Scand 63: 20–28

Peroutka SJ, Snyder SH (1980) Relationship of neuroleptic drug effects at brain dopamine, serotonin, α-adrenergic, and histamine to clinical potency. Am J Psychiatry 137: 1518–1522

Reynolds GP, Rossor MN, Iversen LL (1983) Preliminary studies of human cortical 5-HT2 receptors and their involvement in schizophrenia and neuroleptic drug action. J Neural Transm [Suppl 18]: 273–277

Schmidt AW, Peroutka SJ (1989) 5-Hydroxytryptamine receptor “families”. FASEB J 3: 2242–2249

Whitaker PM, Crow TJ, Ferrier IN (1981) Triatiated LSD binding in frontal cortex in schizophrenia. Arch Gen Psychiatry 38: 278–280

Whitaker PM, Seeman P (1978) Selective labelling of serotonin receptors by D-3H-lysergic acid diethylamide in calf caudate. Proc Natl Acad Sci USA 75: 5783–5787

Wilmot CA, Szczepanik AM (1989) Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain. Brain Res 487: 288–298